The results revealed no significant changes in USP30 expression, confirming that the functional role of USP30-AS1 in breast cancer is independent of USP30. Therefore, the observed phenotypes can be attributed to USP30-AS1 itself rather than indirect regulation by USP30 (Fig. S5C, D). This evidence concerns the gene USP30 and breast carcinoma.